Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARTIVION, INC. Director's Dealing 2017

Feb 24, 2017

31684_dirs_2017-02-24_4b3183ff-ebe1-4577-80f3-2538205b792f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2017-02-22

Reporting Person: Capps Scott B (VP, Clinical Research)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-22 Common Stock M 16667 $7.01 Acquired 128477 Direct
2017-02-22 Common Stock S 11083 $16.4013 Disposed 117394 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-22 Stock Options (Right to Buy) $7.01 M 16667 Disposed 2017-02-22 Common Stock (16667) Direct

Footnotes

F1: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/22/2011

F2: Reflects weighted average price. Range was $16.35 to $16.45 The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.